Results 21 to 30 of about 67,988 (293)

Leukotrienes and leukotriene modifiers in pediatric allergic diseases [PDF]

open access: yes, 2014
Leukotrienes are potent pro-inflammatory lipid mediators derived from arachidonic acid through several enzymatic pathways. They have an essential role in allergic inflammation, where they induce bronchoconstriction, airway edema, and chemotaxis of the ...
El-Ghoneimy, D H, El-Sayed, Z A
core   +1 more source

5-Lipoxygenase: mechanisms of regulation1

open access: yesJournal of Lipid Research, 2009
5-Lipoxygenase (5-LO) catalyzes two steps in biosynthesis of leukotrienes (LTs), a group of lipid mediators of inflammation derived from arachidonic acid (AA).
Olof Rådmark, Bengt Samuelsson
doaj   +1 more source

miRNAs and Leukotrienes in Respiratory Syncytial Virus Infection

open access: yesFrontiers in Pediatrics, 2021
MicroRNAs (miRNAs) are small, non-coding RNAs that regulate posttranscription by binding to 3′-untranslated regions of target mRNAs. Recent functional studies have elucidated mechanisms that miRNAs regulate leukotriene synthesis by perturbing arachidonic
Zhi Liu   +5 more
doaj   +1 more source

Effects of perioperative supplementation with omega-3 fatty acids on leukotriene B4 and leukotriene B5 production by stimulated neutrophils in patients with colorectal cancer: a randomized, placebo-controlled intervention trial

open access: yes, 2014
Omega-3 fatty acids (n-3 FA) may have beneficial clinical and immune-modulating effects in surgical patients. In a randomized, double-blind, prospective, placebo-controlled trial, 148 patients referred for elective colorectal cancer surgery received an n-
Schmidt, E.B.   +20 more
core   +1 more source

Zileuton protects against arachidonic acid/5-lipoxygenase/leukotriene axis-mediated neuroinflammation in experimental traumatic brain injury

open access: yesFrontiers in Pharmacology
IntroductionTraumatic brain injury (TBI) is a leading cause of death and disability globally. Several studies have shown that 5-lipoxygenase (5-LOX) inhibition reduces leukotriene (LT) release and the inflammatory response, attenuating the development of
Xiaofeng Xu   +7 more
doaj   +1 more source

A metabolome-wide case-control study of african american breast cancer patients

open access: yesBMC Cancer, 2023
Background Breast cancer survivors face long-term sequelae compared to the general population, suggesting altered metabolic profiles after breast cancer.
Jiajun Luo   +8 more
doaj   +1 more source

N-Acetyl-leukotriene E\(_4\) is a potent constrictor of rat mesenteric vessels [PDF]

open access: yes, 1988
N-Acetyl-leukotriene E\(_4\) administered to conscious freely moving rats produced a dose-dependent vasoconstriction in the mesenteric vessels which led to profound reduction of blood flow to the gut.
Letts, G.   +2 more
core   +2 more sources

The aryl hydrocarbon receptor regulates lipid mediator production in alveolar macrophages

open access: yesFrontiers in Immunology, 2023
Allergic inflammation of the airways such as allergic asthma is a major health problem with growing incidence world-wide. One cardinal feature in severe type 2-dominated airway inflammation is the release of lipid mediators of the eicosanoid family that ...
Ann-Marie Maier   +14 more
doaj   +1 more source

Leukotriene Inflammatory Mediators Meet Their Match

open access: yes, 2011
The main enzyme in the leukotriene biosynthesis pathway finally yields to crystallization, paving the way for new leukotriene-modifier drugs.
Colin D. Funk
core   +1 more source

Leukotriene signaling in atherosclerosis and ischemia. [PDF]

open access: yes, 2009
International audienceINTRODUCTION: The inflammatory process of atherosclerosis is associated with several pathophysiological reactions within the vascular wall.
Bäck, Magnus, Back, M
core   +1 more source

Home - About - Disclaimer - Privacy